-
How do you feel about ALS research?
The latest breakthrough in ALS research resulted in a new medication, Tofersen (Qalsody®) targets a mutation of the superoxide dismutase 1 (SOD1) gene. The good news is this treatment appears to be successful at slowing down or halting the progression of ALS. The bad news, it only targets about 2% of the pALS, which is approximately 300 people in the United States.
How do you feel about this research?
What research are you following and do you feel hopeful based on what you have read or learned?
Sorry, there were no replies found.
Log in to reply.